Literature DB >> 14502367

Pentoxifylline decreases tumor necrosis factor and interleukin-1 during high tidal volume.

I S Oliveira-Junior1, B V Pinheiro, I D C G Silva, R Salomão, R L Zollner, O S Beppu.   

Abstract

Tumor necrosis factor-alpha (TNF-alpha) is one of the most important proinflammatory cytokines which plays a central role in host defense and in the acute inflammatory response related to tissue injury. The major source of TNF-alpha are immune cells such as neutrophils and macrophages. We tested the hypothesis that pentoxifylline, a methylxanthine derivative, down-regulates proinflammatory cytokine expression during acute lung injury in rats. Male Wistar rats weighing 250 to 450 g were anesthetized ip with 50 mg/kg sodium thiopental and randomly divided into three groups: group 1 (N = 7): tidal volume (V T) = 7 ml/kg, respiratory rate (RR) = 50 breaths/min and normal saline infusion; group 2 (N = 7): V T = 42 ml/kg, RR = 9 breaths/min and normal saline infusion; group 3 (N = 7): V T = 42 ml/kg, RR = 9 breaths/min and pentoxifylline infusion. The animals were ventilated with an inspired oxygen fraction of 1.0, a positive end-expiratory pressure of 3 cmH2O, and normal saline or pentoxifylline injected into the left femoral vein. The mRNA of TNF-alpha rapidly increased in the lung tissue within 180 min of ventilation with a higher V T with normal saline infusion. The concentrations of inflammatory mediators were decreased in plasma and bronchoalveolar lavage (BAL) in the presence of higher V T with pentoxifylline infusion (TNF-alpha: plasma, 102.2+/-90.9 and BAL, 118.2+/-82.1; IL-1 : plasma, 45.2+/-42.7 and BAL, 50.2+/-34.9, P < 0.05). We conclude that TNF-alpha produced by neutrophil influx may function as an alert signal in host defense to induce production of other inflammatory mediators.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502367     DOI: 10.1590/s0100-879x2003001000011

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  6 in total

1.  Co-administration of pentoxifylline and thiopental causes death by acute pulmonary oedema in rats.

Authors:  J Pereda; L Gómez-Cambronero; A Alberola; G Fabregat; M Cerdá; J Escobar; L Sabater; J García-de-la-Asunción; J García-de-la-Asuneión; J Viña; J Sastre
Journal:  Br J Pharmacol       Date:  2006-09-04       Impact factor: 8.739

2.  Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants.

Authors:  Nicole R Dobson; Ravi M Patel; P Brian Smith; Devon R Kuehn; Jennifer Clark; Shilpa Vyas-Read; Amy Herring; Matthew M Laughon; David Carlton; Carl E Hunt
Journal:  J Pediatr       Date:  2014-01-23       Impact factor: 4.406

3.  Suppressive effect of low-level laser therapy on tracheal hyperresponsiveness and lung inflammation in rat subjected to intestinal ischemia and reperfusion.

Authors:  Flávia Mafra de Lima; Luana Vitoretti; Fernando Coelho; Regiane Albertini; Ana Cristina Breithaupt-Faloppa; Wothan Tavares de Lima; Flávio Aimbire
Journal:  Lasers Med Sci       Date:  2012-05-05       Impact factor: 3.161

4.  Pentoxifylline attenuates nitrogen mustard-induced acute lung injury, oxidative stress and inflammation.

Authors:  Vasanthi R Sunil; Kinal N Vayas; Jessica A Cervelli; Rama Malaviya; LeRoy Hall; Christopher B Massa; Andrew J Gow; Jeffrey D Laskin; Debra L Laskin
Journal:  Exp Mol Pathol       Date:  2014-06-02       Impact factor: 3.362

Review 5.  Bench-to-bedside review: Ventilation-induced renal injury through systemic mediator release--just theory or a causal relationship?

Authors:  Jan Willem Kuiper; Rosanna Vaschetto; Francesco Della Corte; Frans B Plötz; A B Johan Groeneveld
Journal:  Crit Care       Date:  2011-08-16       Impact factor: 9.097

6.  Effects of pentoxifylline on TNF-alpha and lung histopathology in HCL-induced lung injury.

Authors:  Itamar Souza Oliveira-Júnior; Itamar Souza de Oliveira-Júnior; Carla Cristina Maganhin; Adriana Aparecida Ferraz Carbonel; Cristina Maria Rodrigues Monteiro; Sâmia Santos Cavassani; Ricardo Martins Oliveira-Filho
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.